The results obtained within this study have revealed a distinct and progressing pattern of claudin-4 expression within the prostate with noncancerous pathological changes as well as in PCa and PCa metastases by RT–PCR and immunohistochemistry of both primary and secondary tumours. Here, CLDN4 is linked to posterior cortical atrophy.